请输入关键字
请输入关键字
订购
*国家
中国
美国
中国香港
中国澳门
中国台湾
阿尔巴尼亚
阿尔及利亚
阿根廷
阿拉伯联合酋长国
阿鲁巴
阿曼
阿塞拜疆
阿森松岛
埃及
埃塞俄比亚
爱尔兰
爱沙尼亚
安道尔
安哥拉
安圭拉
安提瓜和巴布达
奥地利
奥兰群岛
澳大利亚
巴巴多斯
巴布亚新几内亚
巴哈马
巴基斯坦
巴拉圭
巴勒斯坦领土
巴林
巴拿马
巴西
白俄罗斯
百慕大
保加利亚
北马里亚纳群岛
贝宁
比利时
冰岛
波多黎各
波兰
波斯尼亚和黑塞哥维那
玻利维亚
伯利兹
博茨瓦纳
不丹
布基纳法索
布隆迪
朝鲜
赤道几内亚
丹麦
德国
迪戈加西亚岛
东帝汶
多哥
多米尼加共和国
多米尼克
俄罗斯
厄瓜多尔
厄立特里亚
法国
法罗群岛
法属波利尼西亚
法属圭亚那
法属南部领地
梵蒂冈
菲律宾
斐济
芬兰
佛得角
福克兰群岛
冈比亚
刚果(布)
刚果(金)
哥伦比亚
哥斯达黎加
格恩西岛
格林纳达
格陵兰
格鲁吉亚
古巴
瓜德罗普
关岛
圭亚那
哈萨克斯坦
海地
韩国
荷兰
荷属加勒比区
荷属圣马丁
黑山
洪都拉斯
基里巴斯
吉布提
吉尔吉斯斯坦
几内亚
几内亚比绍
加拿大
加纳
加纳利群岛
加蓬
柬埔寨
捷克
津巴布韦
喀麦隆
卡塔尔
开曼群岛
科科斯(基林)群岛
科摩罗
科索沃
科特迪瓦
科威特
克罗地亚
肯尼亚
库克群岛
库拉索
拉脱维亚
莱索托
老挝
黎巴嫩
立陶宛
利比里亚
利比亚
联合国
列支敦士登
留尼汪
卢森堡
卢旺达
罗马尼亚
马达加斯加
马恩岛
马尔代夫
马耳他
马拉维
马来西亚
马里
马其顿
马绍尔群岛
马提尼克
马约特
毛里求斯
毛里塔尼亚
美国本土外小岛屿
美属萨摩亚
美属维尔京群岛
蒙古
蒙特塞拉特
孟加拉国
秘鲁
密克罗尼西亚
缅甸
摩尔多瓦
摩洛哥
摩纳哥
莫桑比克
墨西哥
纳米比亚
南非
南极洲
南乔治亚和南桑威奇群岛
南苏丹
瑙鲁
尼加拉瓜
尼泊尔
尼日尔
尼日利亚
纽埃
挪威
诺福克岛
帕劳
皮特凯恩群岛
葡萄牙
日本
瑞典
瑞士
萨尔瓦多
萨摩亚
塞尔维亚
塞拉利昂
塞内加尔
塞浦路斯
塞舌尔
沙特阿拉伯
圣巴泰勒米
圣诞岛
圣多美和普林西比
圣赫勒拿
圣基茨和尼维斯
圣卢西亚
圣马丁岛
圣马力诺
圣皮埃尔和密克隆群岛
圣文森特和格林纳丁斯
斯里兰卡
斯洛伐克
斯洛文尼亚
斯瓦尔巴和扬马延
斯威士兰
苏丹
苏里南
所罗门群岛
索马里
塔吉克斯坦
泰国
坦桑尼亚
汤加
特克斯和凯科斯群岛
特里斯坦-达库尼亚群岛
特立尼达和多巴哥
突尼斯
图瓦卢
土耳其
土库曼斯坦
托克劳
瓦利斯和富图纳
瓦努阿图
危地马拉
委内瑞拉
文莱
乌干达
乌克兰
乌拉圭
乌兹别克斯坦
希腊
西班牙
西撒哈拉
新加坡
新喀里多尼亚
新西兰
匈牙利
休达及梅利利亚
叙利亚
牙买加
亚美尼亚
也门
伊拉克
伊朗
以色列
意大利
印度
印度尼西亚
英国
英属维尔京群岛
英属印度洋领地
约旦
越南
赞比亚
泽西岛
乍得
直布罗陀
智利
中非共和国
*省份
*城市
*姓名
*电话
*单位
*职位
*邮箱
*请输入验证码
*验证码
B-hTL1A/hα4β7 mice
Strain Name

C57BL/6-Tnfsf15tm2(TNFSF15)Bcgen Itga4tm1(ITGA4)Bcgen 

Itgb7tm1(ITGB7)Bcgen/Bcgen

Common Name 

B-hTL1A/hα4β7 mice

Background

C57BL/6

Catalog Number

113037

Aliases 

TL1, TL1A, TNLG1B, VEGI, VEGI192A;

CD49D, IA4;

NA;

NCBI Gene ID

9966, 3676, 3695

Description


  • TL1A binds to death receptor 3 (DR3) to provide stimulatory signals for downstream signaling pathways, thereby regulating the proliferation, activation, apoptosis of effector cells, and the production of cytokines and chemokines. Soluble decoy receptor 3 (DcR3) may neutralize the effects of sTL1A/DR3. In addition, DcR3 can inhibit apoptosis, reduce inflammation, and prevent tissue damage by neutralizing LIGHT and FasL.
  • Integrin α4β7 is composed of a 150 kD (α4 or CD49d) and a 130 kD (β7) heterodimer, also known as CD49d/β7 or LPAM-1. Belonging to the Ig superfamily, it is found on the majority of peripheral lymphocytes and subsets of thymocytes and bone marrow cells (including mast cell progenitors). Integrin α4β7 binds its ligands, VCAM-1 (CD106), MAdCAM-1 and fibronectin, and plays an important role in lymphocytes adhesion and the direction of migration of blood lymphocytes to the intestine and associated lymphoid tissues.
  • The exons 1-4 of mouse Tl1a gene that encode the extracellular domain were replaced by human TL1A exons 1-4 in B-hTL1A/hα4β7 mice; The exons 2-27 of mouse Itga4 gene that encode the extracellular domain were replaced by human ITGA4 exons 2-27 in B-hTL1A/hα4β7 mice; The exons 2-14 of mouse Itgb7 gene that encode the extracellular domain were replaced by human ITGB7 exons 3-15 in B-hTL1A/hα4β7 mice.
  • Mouse ITGA4 and ITGB7 were only detectable on NK cells, DCs, monocytes and macrophages from spleen of wild-type C57BL/6JNifdc mice. Human ITGA4 and ITGB7 were exclusively detectable in homozygous B-hTL1A/hα4β7 mice, but not in wild-type C57BL/6JNifdc mice. Soluble human TL1A was exclusively detectable in homozygous B-hTL1A/hα4β7 mice but not wild-type C57BL/6JNifdc mice. Humanization of TL1A, ITGA4 and ITGB7 do not change the overall frequency or distribution of immune cell types in spleen, blood and lymph nodes. In TNBS-induced acute colitis in B-hTL1A/hα4β7 mice, treatment with anti-human TL1A antibody and anti-human α4β7 antibody improved the disease characteristics of colitis.
  • Application: This product is used for pharmacological and safety evaluation of autoimmune diseases such as Inflammatory bowel disease, psoriasis and arthritis.

Targeting strategy

Gene targeting strategy for B-hTL1A/hα4β7 mice.

The exons 1-4 of mouse Tl1a gene that encode the extracellular domain were replaced by human TL1A exons 1-4 in B-hTL1A/hα4β7 mice.

The exons 2-27 of mouse Itga4 gene that encode the extracellular domain were replaced by human ITGA4 exons 2-27 in B-hTL1A/hα4β7 mice.

The exons 2-14 of mouse Itgb7 gene that encode the extracellular domain were replaced by human ITGB7 exons 3-15 in B-hTL1A/hα4β7 mice.

Protein expression analysis in spleen


from clipboard

Strain specific ITGA4 and ITGB7 expression analysis in wild-type C57BL/6JNifdc mice and homozygous humanized B-hTL1A/hα4β7 mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6JNifdc mice and homozygous B-hTL1A/hα4β7 mice. Protein expression was analyzed with anti-mouse ITGA4 antibody (Biolegend, 103705), anti-mouse ITGB7 antibody (Biolegend, 120607), anti-human ITGA4 antibody (Biolegend, 304307) anti-human ITGB7 antibody (Invitrogen, MA5-23541) by flow cytometry. Mouse ITGA4 and ITGB7 were only detectable in wild-type C57BL/6JNifdc mice. Human ITGA4 and ITGB7 were exclusively detectable in homozygous B-hTL1A/hα4β7 mice, but not in wild-type C57BL/6JNifdc mice.

from clipboard

Strain specific ITGA4 and ITGB7 expression analysis in wild-type C57BL/6JNifdc mice and homozygous humanized B-hTL1A/hα4β7 mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6JNifdc mice and homozygous B-hTL1A/hα4β7 mice. Protein expression was analyzed with anti-mouse ITGA4 antibody (Biolegend, 103705), anti-mouse ITGB7 antibody (Biolegend, 120607), anti-human ITGA4 antibody (Biolegend, 304307) anti-human ITGB7 antibody (Invitrogen, MA5-23541) by flow cytometry. Mouse ITGA4 and ITGB7 were only detectable in wild-type C57BL/6JNifdc mice. Human ITGA4 and ITGB7 were exclusively detectable in homozygous B-hTL1A/hα4β7 mice, but not in wild-type C57BL/6JNifdc mice.

from clipboard

Strain specific ITGA4 and ITGB7 expression analysis in wild-type C57BL/6JNifdc mice and homozygous humanized B-hTL1A/hα4β7 mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6JNifdc mice and homozygous B-hTL1A/hα4β7 mice. Protein expression was analyzed with anti-mouse ITGA4 antibody (Biolegend, 103705), anti-mouse ITGB7 antibody (Biolegend, 120607), anti-human ITGA4 antibody (Biolegend, 304307) anti-human ITGB7 antibody (Invitrogen, MA5-23541) by flow cytometry. Mouse ITGA4 and ITGB7 were only detectable in wild-type C57BL/6JNifdc mice. Human ITGA4 and ITGB7 were exclusively detectable in homozygous B-hTL1A/hα4β7 mice, but not in wild-type C57BL/6JNifdc mice.

from clipboard

Strain specific ITGA4 and ITGB7 expression analysis in wild-type C57BL/6JNifdc mice and homozygous humanized B-hTL1A/hα4β7 mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6JNifdc mice and homozygous B-hTL1A/hα4β7 mice. Protein expression was analyzed with anti-mouse ITGA4 antibody (Biolegend, 103705), anti-mouse ITGB7 antibody (Biolegend, 120607), anti-human ITGA4 antibody (Biolegend, 304307) anti-human ITGB7 antibody (Invitrogen, MA5-23541) by flow cytometry. Mouse ITGA4 and ITGB7 were only detectable in wild-type C57BL/6JNifdc mice. Human ITGA4 and ITGB7 were exclusively detectable in homozygous B-hTL1A/hα4β7 mice, but not in wild-type C57BL/6JNifdc mice.

Protein expression analysis

from clipboard

Soluble TL1A expression analysis in B-hTL1A/hα4β7 mice by ELISA. Bone marrow derived dendritic cells (BMDCs) were produced by culturing the bone marrow from wild-type C57BL/6JNifdc mice and homozygous B-hTL1A/hα4β7 mice (female, 8 weeks-old, n=3), which were stimulated with 1 μg/mL LPS in vitro for 18h. After stimulation, the supernatants were collected and the levels of soluble TL1A were measured using a species-specific human TL1A ELISA kit (R&D, DY1319-05). Soluble human TL1A was exclusively detectable in homozygous B-hTL1A/hα4β7 mice but not wild-type C57BL/6JNifdc mice. Values are expressed as mean ± SEM. ND: not detectable.

Frequency of leukocyte subpopulations in spleen

from clipboard

Frequency of leukocyte subpopulations in spleen by flow cytometry. Splenocytes were isolated from wild-type C57BL/6JNifdc mice and homozygous B-hTL1A/hα4β7 mice (female, 8-week-old, n=3). A. Flow cytometry analysis of the splenocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequencies of T cell subpopulations. Percentages of T cells, B cells, NK cells, DCs, monocytes, macrophages, neutrophils, CD4+ T cells, CD8+ T cells and Tregs in B-hTL1A/hα4β7 mice were similar to those in C57BL/6JNifdc mice, demonstrating that humanization of TL1A, ITGA4 and ITGB7 do not change the frequency or distribution of these cell types in spleen. Values are expressed as mean ± SEM.

Frequency of leukocyte subpopulations in blood

from clipboard

Frequency of leukocyte subpopulations in blood by flow cytometry. Blood cells were isolated from wild-type C57BL/6JNifdc mice and homozygous B-hTL1A/hα4β7 mice (female, 8-week-old, n=3). A. Flow cytometry analysis of the blood cells was performed to assess the frequency of leukocyte subpopulations. B. Frequencies of T cell subpopulations. Percentages of T cells, B cells, NK cells, DCs, monocytes, macrophages, neutrophils, CD4+ T cells, CD8+ T cells and Tregs in B-hTL1A/hα4β7 mice were similar to those in C57BL/6JNifdc mice, demonstrating that humanization of TL1A, ITGA4 and ITGB7 do not change the frequency or distribution of these cell types in blood. Values are expressed as mean ± SEM.

Frequency of leukocyte subpopulations in lymph nodes

from clipboard

Frequency of leukocyte subpopulations in lymph node by flow cytometry. Leukocytes were isolated from wild-type C57BL/6JNifdc mice and homozygous B-hTL1A/hα4β7 mice (female, 8-week-old, n=3). A. Flow cytometry analysis of the leukocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequencies of T cell subpopulations. Percentages of T cells, B cells, NK cells, CD4+ T cells, CD8+ T cells and Tregs in B-hTL1A/hα4β7 mice were similar to those in C57BL/6JNifdc mice, demonstrating that humanization of TL1A, ITGA4 and ITGB7 do not change the frequency or distribution of these cell types in lymph nodes. Values are expressed as mean ± SEM.

TNBS induced acute colitis in B-hTL1A/hα4β7 mice


from clipboard

TNBS solution was instilled into the colon lumen of B-hTL1A/hα4β7 mice (female, 8-10 weeks-old, n=10). The control group (Sham) received intrarectal injections of 50% ethanol. The treatment groups received anti-human TL1A antibody RVT-3101 (10 mpk, provided by WuXi AppTec), anti-human α4β7 antibody Vedolizumab (10 mpk, provided by WuXi AppTec) alone or in combination. Body weight and DAI score were recorded daily. On day 5, the mice were sacrificed, and colon length and weight were recorded. (A) Body weight change. (B) DAI score. (C) Colon Index. (D) Colon photo. A TNBS-induced acute colitis model was established in B-hTL1A/hα4β7 mice. Administration of anti-human TL1A antibody RVT-3101 and anti-human α4β7 antibody Vedolizumab effectively improved TNBS-induced acute colitis, and their combination provided better efficacy. The results indicate that B-hTL1A/hα4β7 mice are a powerful tool for evaluating in vivo efficacy of the combination of anti-human TL1A antibody and anti-human α4β7 antibody. Values are expressed as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, versus Vehicle, ANOVA.

Note: This experiment was conducted by WuXi AppTec using in B-hTL1A/hα4β7 mice.

from clipboard

TNBS solution was instilled into the colon lumen of B-hTL1A/hα4β7 mice (female, 8-10 weeks-old, n=10). The control group (Sham) received intrarectal injections of 50% ethanol. The treatment groups received anti-human TL1A antibody RVT-3101 (10 mpk, provided by WuXi AppTec), anti-human α4β7 antibody Vedolizumab (10 mpk, provided by WuXi AppTec) alone or in combination. Body weight and DAI score were recorded daily. On day 5, the mice were sacrificed, and the intestinal mucosa and serum were collected for cytokine analysis. (A) The concentrations of IL-1β, IL-6, IL-17A, IFN-γ, TNF-α in intestinal mucosa. (B) The concentrations of IL-1β, IL-6, IL-17A, IFN-γ, TNF-α in serum. A TNBS-induced acute colitis model was established in B-hTL1A/hα4β7 mice. Administration of anti-human TL1A antibody RVT-3101 and anti-human α4β7 antibody Vedolizumab effectively improved TNBS-induced acute colitis, and their combination provided better efficacy. The results indicate that B-hTL1A/hα4β7 mice are a powerful tool for evaluating in vivo efficacy of the combination of anti-human TL1A antibody and anti-human α4β7 antibody. Values are expressed as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, versus Vehicle, ANOVA.

Note: This experiment was conducted by WuXi AppTec using in B-hTL1A/hα4β7 mice.